OR WAIT null SECS
September 20, 2022
Experts from Umoja Biopharma dive into cell therapy development in this episode of the Drug Solutions Podcast, including the greatest advancements in cell therapy to date, areas for improvement, the biggest trends in cell therapy development, and retention as a pain point.
September 03, 2022
It is argued that orthogonal quantitative methods can be used to establish primary working standards. An example details how to calculate the expanded measurement uncertainty (U) for the certified assay value by considering two orthogonal assay methods.
It is possible to overcome some of the limitations of traditional dosage forms by employing alternative drug delivery formulation strategies.
August 03, 2022
Industry is adapting to the increasing complexity and poor solubility and bioavailability of molecules in the pipeline.
The purpose of this article was to demonstrate the application of a new thermogelling matrix in the healing of wounds.
August 02, 2022
In this episode, Fernando Muzzio provides greater insight into a novel approach to improving drug solubility—continuous melt coating.
July 03, 2022
Biologics are forming a greater proportion of the development pipeline, but there are still some formulation difficulties to overcome to ensure clinical and commercial success.
Lack of toxicity data and poor physicochemical properties must be overcome.
June 03, 2022
Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.
The right processes used with the right excipient combinations address evolving formulation needs.